ARAP3 inhibitors belong to a category of chemical compounds designed to target and modulate the activity of ARAP3, which stands for Arf GAP with Rho GAP domain, Ankyrin repeat, and PH domain-containing protein 3. ARAP3 is a multifunctional protein that plays a pivotal role in cellular signal transduction and membrane trafficking processes. It is a member of the Rho family of small GTPases and possesses domains that interact with various signaling molecules and cellular structures. ARAP3 is involved in the regulation of intracellular trafficking, cytoskeleton dynamics, and cell adhesion. Inhibitors designed to target ARAP3 aim to interfere with its function or activity, thereby influencing the cellular processes and signaling pathways that rely on ARAP3.
The mechanisms by which ARAP3 inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may target specific domains or binding sites on the ARAP3 protein, preventing its interactions with small GTPases or other signaling molecules. Others may modulate the enzyme activity of ARAP3, affecting its ability to catalyze the hydrolysis of GTP. By inhibiting ARAP3, these compounds have the potential to impact cellular processes such as membrane trafficking, cell adhesion, and cytoskeletal rearrangements. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of ARAP3 inhibition, furthering our understanding of its significance in cellular biology and intracellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, might influence ARAP3 expression indirectly through its role in modulating PI3K/Akt signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, might modulate ARAP3 expression as part of its broad effects on cell growth and proliferation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MAPK inhibitor, could influence ARAP3 expression by affecting MAPK signaling pathways, which are involved in various cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, might alter ARAP3 expression through its impact on the JNK signaling pathway, involved in cell stress responses. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, may affect ARAP3 expression by modulating the p38 MAPK pathway, known for its role in inflammatory responses and stress. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, an EGFR inhibitor, could potentially modulate ARAP3 expression through its effects on EGFR signaling, which is linked to cell migration and angiogenesis. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a Src family kinase inhibitor, might impact ARAP3 expression as part of its role in regulating signaling pathways associated with cell migration. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib, another EGFR inhibitor, may influence ARAP3 expression by affecting EGFR-mediated signaling pathways. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, a tyrosine kinase inhibitor, could affect ARAP3 expression through its broad impact on cellular signaling and proliferation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a kinase inhibitor, might modulate ARAP3 expression by targeting multiple kinases involved in cell signaling and angiogenesis. | ||||||